Indian Drug Companies Urge Government to Stop Evergreening Tactics
India's pharmaceutical companies urged the government not to reopen issues such as compulsory licensing and Bolar exception as it prepares to amend the Patent Act, the Economic Times of India reported....To view the full article, register now.
Already a subscriber? Click here to view full article